InVivoMAb anti-mouse PD-1 (CD279)

RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer. Wang W et al., 2018 Nov 12, Cancer Cell

PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Gordon SR et al., 2017 May 25, Nature

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints. Koyama S et al., 2016 Feb 17, Nat Commun

STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment. Koyama S et al., 2016 Mar 1, Cancer Res

Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade. Cooper ZA et al., 2014 Jul, Cancer Immunol Res

Negative role of inducible PD-1 on survival of activated dendritic cells. Park SJ et al., 2014 Apr, J Leukoc Biol

Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors. Duraiswamy J et al., 2013 Jun 15, Cancer Res

CD80 expression on B cells regulates murine T follicular helper development, germinal center B cell survival, and plasma cell generation. Good-Jacobson KL et al., 2012 May 1, J Immunol

Role of the immune modulator programmed cell death-1 during development and apoptosis of mouse retinal ganglion cells. Chen L et al., 2009 Oct, Invest Ophthalmol Vis Sci

Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: distinct roles. Menke J et al., 2007 Dec 1, J Immunol